NeuralCipher Source record
Optogenetic fMRI reveals therapeutic circuits of subthalamic nucleus deep brain stimulation
DOI: 10.1101/2024.02.22.581627
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
20.927 articles found
Open access
Melatonin derivative 6a as a PARP-1 inhibitor for the treatment of Parkinson's disease.
DOI: 10.3389/fphar.2024.1363212PMID: 38476326
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Therapeutics for neurodegenerative diseases by targeting the gut microbiome: from bench to bedside.
DOI: 10.1186/s40035-024-00404-1PMID: 38414054
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Focused ultrasound therapy in movement disorders: management roadmap toward optimal pathway organization.
DOI: 10.3389/fneur.2024.1356310PMID: 38595849
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease.
DOI: 10.1007/s11033-024-09294-yPMID: 38400887
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Evaluating the effectiveness of coagulation-flocculation treatment on a wastewater from the moroccan leather tanning industry : An ecological approach.
DOI: 10.1016/j.heliyon.2024.e27056PMID: 38463895
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Novel and experimental therapeutics for the management of motor and non-motor Parkinsonian symptoms.
DOI: 10.1007/s10072-023-07278-7PMID: 38388896
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
Understanding Drug-Induced Movement Disorders: Causes, Symptoms, and Treatment
DOI: 10.20944/preprints202402.1258.v1
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record
GLP-1 Receptor Agonists: A New Challenge in Parkinson’s Disease Treatment
DOI: 10.20944/preprints202402.1245.v1
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
BACE1 Inhibition Utilizing Organic Compounds Holds Promise as a Potential Treatment for Alzheimer's and Parkinson's Diseases.
DOI: 10.1155/2024/6654606PMID: 38425997
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Gold Nanoparticles in Parkinson's Disease Therapy: A Focus on Plant-Based Green Synthesis.
DOI: 10.7759/cureus.54671PMID: 38524031
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access
Potential Therapeutic Properties of <i>Olea europaea</i> Leaves from Selected Cultivars Based on Their Mineral and Organic Profiles.
DOI: 10.3390/ph17030274PMID: 38543060
A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.